Robb Gary Charles

Average Profitability
72.23%
Insider Buys Quantity
1
Insider Buys Sum
$54,588.24
Insider Sells Quantity
25
Insider Sells Sum
$11.72M

Insider Activity of Robb Gary Charles

According to the SEC Form 4 filings, Robb Gary Charles, being in a position of

  1. Chief Business Officer at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 43694 shares for $1.52M,
    over all time since 2017-05-04, has bought 5600 shares for $54,588, and sold 462710 shares for $11.72M.

The largest purchase of all time was on 2017-05-04 and amounted to 5600 shares of Corcept Therapeutics Incorporated for $54,588.

The largest sale of all time was on 2021-02-12 and amounted to 112100 shares of Corcept Therapeutics Incorporated for $3.16M.

Biography of Robb Gary Charles

No biography is available at this moment.

2024-10-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0113%
$46.28$509,080+1.86%
2024-08-26SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
3,101
0.003%
$35.71$110,737+29.8%
2024-07-01SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0109%
$32.49$357,3900%
2024-05-28SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
11,000
0.0102%
$30.39$334,294+10.77%
2023-12-06SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,212
0.006%
$27.01$167,786+5.83%
2023-12-05SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
1,381
0.0013%
$26.27$36,277+8.01%
2023-09-19SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
5,000
0.0048%
$32.74$163,677-19.65%
2023-05-10SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
14,000
0.013%
$24.07$336,980+3.38%
2023-05-09SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
30,000
0.0279%
$23.87$716,100+4.11%
2022-11-23SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
186
0.0002%
$26.03$4,842-9.77%
2022-11-22SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
4,814
0.0045%
$26.03$125,308-9.87%
2022-11-18SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
13,401
0.0124%
$26.43$354,188-11.54%
2022-11-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
10,000
0.0093%
$26.06$260,600-9.63%
2022-09-07SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
50,000
0.0462%
$26.06$1.3M-10.86%
2022-07-06SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
45,000
0.0417%
$26.00$1.17M-8.78%
2022-05-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,127
0.0058%
$19.57$119,928+21.74%
2022-03-17SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
4,988
0.0047%
$24.67$123,054-1.51%
2021-09-15SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
47,853
0.0415%
$20.49$980,742+7.32%
2021-09-14SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
806
0.0007%
$20.76$16,736+5.99%
2021-09-13SaleCorcept Therapeutics Incorporated
CORT
Chief Business Officer
6,341
0.0055%
$20.89$132,445+3.45%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.